Indeterminate Dendritic Cell Sarcoma in a Patient with Myelodysplastic Syndrome.
Jia Liu,Shibao Zheng,Jiu‐Hong Li,Ying Guo,Litao Zhang,Xinghua Gao,Hong‐Duo Chen
DOI: https://doi.org/10.1097/dad.0000000000001073
2018-01-01
Abstract:To the Editor: Indeterminate dendritic cell tumor (IND-DCT), also called indeterminate cell (IC) histiocytosis (ICH), is a neoplastic proliferation of spindled to ovoid cells with phenotypic features similar to ICs. These neoplasms are extraordinarily rare, and little is known about their etiology, pathogenesis, and prognostic factors. The diagnosis remains challenging as their histological classification and phenotypic definition have not been well established. We encountered an unusual case of cutaneous malignant neoplasm occurring in the context of myelodysplastic syndrome (MDS). These tumor cells exhibited an immunophenotypic profile similar to Langerhans cells; in particular, they were CD1a and S100 positive but Langerin/CD207 negative. We proposed a diagnosis of indeterminate dendritic cell sarcoma (IND-DCS) with MDS in this patient. A 77-year-old male patient presented to our clinic with 2 crusted masses, one on his left temporal region and the other on the right inguinal fold. The lesions had been there over 1 year. A biopsy was taken from the right temporal lesion 3 months ago in an outside hospital and was interpreted as an undifferentiated malignant neoplasm. The lesion in the right inguinal fold was excised subsequently 1 month before presentation without histopathologic examination. The patient's medical history was remarkable for leukopenia, resulting from MDS for 5 years and renal insufficiency for 2 years. On physical examination, a 5.0 × 4.5 cm ulcerated and crusted plaque with ill-defined erythematous border was noted on the left temporal region (Fig. 1) and a 2-cm nontender lymph node was palpated on his left neck. An 8-cm linear scar corresponding to the previous surgery was found in the right inguinal fold, as well as a 2-cm palpable lymph node. A peripheral blood count revealed pancytopenia (total leucocytes: 1.04 × 109/L, reference range: 3.90∼9.50 × 109/L; lymphocytes: 0.88 × 109/L, reference range: 1.10∼3.20 × 109/L; neutrophils: 0.09 × 109/L, reference range: 1.80∼6.30 × 109/L; erythrocytes: 1.93 × 1012/L, reference range: 3.80∼5.10 × 1012/L; hemoglobin: 62 g/L, reference range: 130∼175 g/L; platelets: 70 × 109/L, reference range: 125∼350 × 109/L). Other laboratory work-up, including liver function tests, renal function tests, and serum tumor markers (carcinoembryonic antigen, alpha-fetoprotein, carbohydrate antigen 12-5, carbohydrate antigen 15-3, and carbohydrate antigen 19-9), were all within the normal range. Computerized tomography of the chest revealed bilateral pleural effusion; however, cytology of the aspirate failed to reveal malignant cells. Whole-body positron emission tomography–computerized tomography revealed hypermetabolic masses in both the left temporal and right inguinal fold regions, and a diffuse but unevenly increased metabolic rate in the bone marrow. Periodically repeated bone marrow cytology over the following 3 years all consistently showed hyperplasia and morphological abnormalities of the erythrocytic, granulocytic, and megakaryocytic series.FIGURE 1.: A tumor mass (approximately 5 × 4.5 cm) with central dusky crust and peripheral erythematous border on the left temple (red arrows).The skin biopsy taken from the left temporal region revealed an overlying attenuated epidermis with a dense and diffuse dermal infiltrate (Fig. 2A). At high power, the neoplastic cells revealed pleomorphic nuclei with fine chromatin, conspicuous nucleoli, and abundant eosinophilic cytoplasm. Abnormal mitotic figures were easily identified. Occasional lymphocytes were found mainly at the periphery of the neoplastic sheets, some admixed with neoplastic cells (Fig. 2B). Immunohistochemical study showed that (Fig. 3) the neoplastic cells were strongly positive for CD1a, S-100, CD31, CD68, and lysozyme, focally positive for CD56, and negative for Langerin/CD207, CD3, CD4, CD11c, CD20, CD21, CD33, CD34, CD35, CD43, CD45RA, CD117, CD123, CD163, myeloperoxidase, and Melan A. Over 50% of the neoplastic population was positive for Ki-67.FIGURE 2.: At a low power, a dense and diffuse dermal infiltrate with attenuated overlying epidermis (A, original magnification: ×100). At high power (B, original magnification: ×400), the neoplastic cells with pleomorphic nuclei, fine chromatin, conspicuous nucleoli, and abundant eosinophilic cytoplasm. Atypical mitosis present, some lymphocytes admixed with the neoplastic cells.FIGURE 3.: On immunohistochemical study, the neoplastic cells were strongly positive for CD1a in a membrane pattern (A), S100 in both cytoplasmic and nuclear pattern (B), also positive for CD31 (C), CD68 (D), and lysozyme (E). CD207 (F) negative.Based on these findings, a diagnosis of IND-DCS was made. Conservative therapies such as apheresis and anti-inflammatory treatments were given during the patient's hospitalization. Considering the pancytopenia at the time of presentation with a medical history of MDS in this patient, neither chemotherapy nor radiotherapy was recommended by hematology, oncology, and radiation oncology consultants in our hospital. The patient was discharged from the hospital after the restoration of peripheral blood cell counts. A wide surgical excision of the left temporal lesion was performed in an outside hospital. The surgical wound healed well; however, this patient reported the occurrence of multiple purpuric skin lesions distributed on the trunk and extremities by a telephone follow-up 2 months after discharge from our hospital. He then underwent 2 other operations to remove the recurrent lesions in an outside hospital and died after a respiratory infection 4 months after discharge from our hospital. Histiocytic neoplasms are derived from mononuclear phagocytes (macrophages and dendritic cells). These tumors are rare, and their diagnosis is challenging for both pathologists and clinicians. According to the WHO classification of tumors of the hematopoietic and lymphoid tissues, these tumors can be classified into histiocytic sarcoma, Langerhans cell histiocytosis/sarcoma, interdigitating dendritic cell tumor/sarcoma, follicular dendritic cell sarcoma, fibroblastic reticular cell tumor, IND-DCT, and disseminated juvenile xanthogranuloma.1 This classification is generally based on the immune markers expressed on the tumor cells. Briefly, histiocytes consistently express CD68 and lysozyme; interdigitating cells express CD68 and S-100; and follicular dendritic cells express CD21, but none of these cells express CD1a.2 In this case, those cytologically malignant cells were strongly positive for CD1a and S-100; thus, Langerhans cell sarcoma was the most suspicious diagnosis at first, but subsequent immunochemical detection was negative for Langerin/CD207 and confirmed by 2 other laboratories. This phenotypic feature suggested that these tumor cells may be derived from IC. The neoplastic proliferation of IC, an alleged precursor of Langerhans cell, is known as IND-DCT or ICH. These neoplasms are extraordinarily rare. According to Pacifico et al, no more than 45 cases of IND-DCT or ICH have been reported, and most of these cases occurred in 2 main clinical patterns: disseminated multiple papulonodular lesions with a diameter of 2∼10 mm or a single papulonodular lesion with a diameter of approximately 10 mm.3 Other rare presentations include leonine face, generalized eroded papules, and crusts.4,5 Most patients with ICH have a complex clinical–pathologic appearance and a benign course, which suggested that ICH may be a reactive pattern rather than a neoplastic process.3 Moreover, it has been reported that IC infiltration could be found in some reaction condition such as scabies, pityriasis rosea, and insect bites.6–8 We interpreted this condition as IND-DCS, as proposed by Deng A9 because our patient presented with rapidly growing masses, and dermatopathological examination showed marked cytologically malignant cells with immunophenotypic features of IC. CD31, also known as platelet endothelial cell adhesion molecule-1, is a transmembrane glycoprotein identified on endothelial cells, platelets, monocytes, neutrophils, subsets of lymphocytes, bone marrow stem cells, trophoblasts, and macrophages. IC has not been reported to be positive for CD31 in the literature. The significance of CD31 in IND-DCS remains unknown. MDS are clonal disorders of the hematopoietic stem cells characterized by peripheral cytopenia because of ineffective hematopoiesis. The concurrence of IND-DCS and MDS has not been reported previously, and it is difficult to discriminate whether the IND-DCS is the consequence or just concurrence to MDS in our case.